[en] Objectives - Several devices have been proposed as an alternative to manual compression (MC) for femoral access management (FAME) following catheterization. Although these devices allow earlier ambulation, they have not always been shown to reduce vascular complications. As a consequence, their cost efficacy is not obvious. Methods - During MC a special catheter deployed temporarily within the artery to achieve haemostasis (Bio-DISC (TM)) (BD) was compared with an anchor-collagen based system Angio-Seal (TM) (AS) among 463 consecutive patients undergoing PCI.We examined vascular or systemic complications, nursing time spent to puncture site management and patient's satisfaction. Results - Relative contra-indications to the use of vascular closure devices were encountered in 158 patients. There were no significant differences in baseline characteristics between the patients assigned to each of the 3 treatment groups. The deployment success rate was 98% for AS and 90% for BD (p = 0.037).Vascular complications occurred in 10.8%, 4.0% and 5.8% (p: NS) of MC, AS and BD patients, respectively. The longer sheath dwell time contributed to most of the complications in MC and BD. Nursing time spent for access management was 48.9 min in MC; 28.1 min in BD and 9.9 min in AS (p < 0.0001). Satisfaction score above 70 was noted in 46%, 86% and 92% of patients managed by MC, BD and AS, respectively. Conclusion - AS use is associated with fewer complications, improved patient well being and saves 39 minutes of nursing time. The additional cost of AS is justified when used in selected patients undergoing PCI.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
Doneux, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Martinez, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Gach, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Bellekens, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Language :
English
Title :
Femoral access management: comparison between two different vascular closure devices after percutaneous coronary intervention
Semler HJ. Transfemoral catheterization: mechanical versus manual control of bleeding. Radiology 1985; 154: 234-5.
Simon A, Bumgarner B, Clark K, Israel S. Manual versus mechanical compression for femoral artery hemostasis after cardiac catheterization. Am J Crit Care 1998; 7: 308-13.
Lehmann, KG, Heath-Lange SJ, Ferris ST. Randomized comparison of hemostasis techniques after invasive cardiovascular procedures. Am Heart J 1999; 138: 1118-25.
Balzer JO, Scheinert D, Diebold T, Haufe M, Vogl TJ, Biamino G. Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: A study of 930 patients. Cathet Cardiovasc Interv 2001; 53: 174-81.
Rinder MR, Tamirisa PK, Taniuchi M, Kurz HI, Mumm K, Lasala JM. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions. Cathet Cardiovasc Interv 2001; 54: 146-51.
Kahn ZM, Kumar M, Hollander G, Frankel R. Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Cathet Cardiovasc Interv 2002; 55: 8-13.
Ward S, Casale P, Raymond R, Kussmaul W. Simpfendorfer C. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol 1998; 81: 569-72.
Kapadia SR, Raymond R, Knopf W, Jenkins S, Chapekis A, Ansel G, Rothbaum D, Kussmaul W, Teirstein P, Casale P, Oster L, Simpfendorfer C. The 6 Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol 2001; 87: 789-91.
Resnic FS, Blake GJ, Ohno-Machado L, Selwyn AP, Popma JJ, Rogers C. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein Ub-IIIa inhibitors. Am J Cardiol 2001; 88: 493-6.
Mooney MR, Ellis SG, Gershony G, Yehyawi KJ. Kummer B, Lowrie M. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the Duett vascular closure device. Cathet Cardiovasc Int 2000; 50: 96-102.
Zhang ZF, Mahoney EM, Gershony G, Ellis S, Saucedo JF, Talley JD, Feldman T, Weintraub WS. Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial. Am Heart J 2001; 142: 982-8.
Ellis SG, Mooney M, Talley DJ, Silber S, Teirstein PS, Rodriguez R, Sanborn TA, Feldman T, Leon M, Collins TJ, Wilentz JR, Saucedo JF, Leimgruber PP, Pichard AD, Cohen DJ, Ramee SR, Heuser RR, Kuntz RE, Gershony G. Assessment of the safety and efficacy of the DUETT vascular hemostasis device: Final results of the Safe and Effective Vascular Hemostasis (SEAL) trial. Am Heart J 2002; 143: 612-9.
Bilodeau L, Doucet S, Tanguay JF, L'Allier P, Pagé D, Sylvestre D. The BioDISC™ arteriotomy system. Am J Cardiol 2000; 86 (suppl 8A): 57i (abstract).
André ML, Goicolea J, Argibay V, Vázquez A, Guillén P, Gómez M, Ruiz R, Sanmartín M, Mantilla R. Safety and efficacy of an early deambulation protocol after PTCA with an angio-seal device. Rev Esp Cardiol 2001; 54: 1264-70 (in Spanish).
Duffin DC, Muhlestein JB, Allison SB, Home BD, Fowles RE, Sorensen SG, Revenaugh JR, Bair TL, Lappe DL. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between two different vascular closure devices. J Invas Cardiol 2001; 13: 354-62.
Morice MC, Dumas P, Lefèvre T, Loubeyre C, Louvard Y, Piéchaud JF. Systematic use of transradial approach or suture of the femoral artery after angioplasty: attempt at achieving zero access site complications. Cathet Cardiovasc Interv 2000; 51: 417-21.
Sesana M, Vaghetti M, Albiero R, Corvaja N, Martini G, Sivieri G, Colombo A. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invas Cardiol 2000; 12: 395-9.
Cura FA, Kapadia SR, L'Allier PL, Schneider JP, Kreindel MS, Silver MJ, Yadav JS, Simpfendorfer CC, Raymond RE, Tuzcu EM, Franco I, Whitlow PL, Topol EJ, Ellis SG. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 2000; 86: 780-2.
Dangas G, Mehran R, Lansky AJ, Faraj H, Negoita M, Astatkie M, Santiago M, Pichard AD, Stone GW Leon MB. Arteriotomy closure devices versus manual compression after percutaneous coronary interventions: is there a difference in vascular complications? J Invas Cardiol 2000; 12: 145-50.
Smith TP. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg 2001; 182: 658-62.
Johanning JM. Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg 2001; 34: 983-5.
Cooper CL, Miller A. Infectious complications related to the use of the angio-seal hemostatic puncture closure device. Cathet Cardiovasc Interv 1999; 48: 301-3.
Warren BS, Warren SG, Miller SD. Predictors of complications and learning curve using the Angio-Seal™ closure device following interventional and diagnostic catheterization. Cathet Cardiovasc Interv 1999; 48: 162-6.
